Hand-Foot Syndrome Clinical Trial
Official title:
The Efficacy of Acupuncture and Laser Acupuncture in Treating Chemotherapy or Target Therapy-induced Hand-foot Syndrome
Chemotherapy or target therapy-induced hand-foot syndrome in cancer patients affects the quality of life. At present, there is no better treatment for this side effect of chemotherapy or target therapy. In severe cases, it is necessary to reduce the dose of chemotherapy or target therapy, which may affect the progress and effect of chemotherapy. In recent years, acupuncture has been widely used for many side effects of chemotherapy, such as numbness of hands and feet, gastrointestinal discomfort, and dizziness. There have been many studies have proved to be effective, but quite few studies explored the acupuncture treatment improves the hand-foot syndrome caused by chemotherapy or target therapy in cancer patients. Therefore, the investigators expect to evaluate the efficacy of acupuncture, and applying acupuncture or laser acupuncture to improve hand-foot syndrome caused by chemotherapy or target therapy in cancer patients in the future.
The investigators design a single-center, sham-controlled, assessor- and subject- blind, randomized clinical trial. 60 subjects will be equally and randomly divided into an acupuncture group, laser acupuncture, and sham-laser acupuncture groups in the 6-week trial. Each subject receives acupuncture, laser acupuncture, or sham-laser acupuncture three times a week for three consecutive weeks depending on their group, with a total of 9 times interventions. Outcome measures include Common adverse events evaluation standard version 5.0 (CTCAE) and Visual Analogue Scale (VAS), Dermatology Life Quality Index (DLQI) and assessment of cancer patients' quality of life questionnaire (EORTC QLQ-C30). ANSWatch and Thermal Image Camera are also used to assess those subjects. Those outcome measures will be conducted at baseline, the 3rd and the 6th week after the interventions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04592731 -
Acetylated Natural Nucleotides in Treating Hand-foot Syndrome
|
N/A | |
Completed |
NCT05755646 -
Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial
|
N/A | |
Completed |
NCT00446147 -
Study of Pyridoxine for Hand-Foot Syndrome
|
Phase 3 | |
Completed |
NCT01609166 -
Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome
|
Phase 2 | |
Terminated |
NCT03173365 -
The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients
|
Phase 2 | |
Recruiting |
NCT04979078 -
Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
|
N/A | |
Recruiting |
NCT05165069 -
The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome
|
Phase 3 | |
Recruiting |
NCT05348278 -
Urea Cream Prevention for Capecitabine Associated Hand Foot Syndrome
|
Phase 2/Phase 3 | |
Recruiting |
NCT04833998 -
Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine
|
Phase 2 |